Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study

Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study

Introduction Immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, have significantly improved the clinical outcomes of various malignancies. However, they also cause immune-related adverse events (irAEs) that can be challenging to predict, prevent and t...

Full description

Bibliographic Details
Main Authors: Geertruida H De Bock, Delphine Maucort-Boulch, Clémence Leyrat, Amélie Anota, Stephane Dalle, Susana Puig, Marie Préau, Mohammad S Jalali, Marie-Jose Kersten, Martijn GH van Oijen, Mathieu Fauvernier, Petra C. Vinke, Marc Combalia, Anne Mea Spanjaart, Maria Gomes da Silva, Aurore Fouda Essongue, Aurélie Rabier, Myriam Pannard, Amal Elgammal, Mike Papazoglou, Mohand-Said Hacid, Catherine Rioufol, Erick Suazo-Zepeda, Ananya Malhotra, Emmanuel Coquery, Elsa Coz
Format: Article
Language:English
Published: BMJ Publishing Group 2023-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/4/e069090.full

Internet

https://bmjopen.bmj.com/content/13/4/e069090.full

Similar Items